Single-particle cryo-EM characterization of AMPA receptor functional states

AMPA 受体功能状态的单颗粒冷冻电镜表征

• 批准号: 9573053
• 负责人: Alexander Sobolevsky
• 金额: $ 37.41万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-01 至 2023-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9573053
• 关键词: AMPA Receptors; Agonist; Alzheimer' s Disease; Binding; Biochemistry; Biological Assay; Carnitine O-Palmitoyltransferase; Cell membrane; Clinical; Communication; Complex; Cryoelectron Microscopy; Crystallization; Crystallography; Data; Detection; Drug Design; Drug Targeting; Economics; Electrophysiology (science); Epilepsy; Fluorescence; Functional disorder; Future; Genes; Glutamate Receptor; Goals; Heterogeneity; Individual; Ion Channel; Ischemia; Knowledge; Length; Ligand Binding Domain; Light; Link; Mediating; Membrane; Mental disorders; Methodology; Modernization; Molecular; Molecular Conformation; Molecular Sieve Chromatography; Mutagenesis; Neurons; Pathologic; Pharmaceutical Preparations; Physiological; Population Heterogeneity; Primary Lateral Sclerosis; Process; Property; Proteins; Rattus; Receptor Activation; Regulation; Research; Resolution; Sampling; Signal Transduction; Site-Directed Mutagenesis; Structural Models; Structure; Synapses; Testing; Work; X-Ray Crystallography; base; cognitive function; cognitive process; desensitization; design; genetic regulatory protein; improved; nervous system disorder; neurotransmission; novel therapeutics; particle; patch clamp; positive allosteric modulator; protein expression; receptor; receptor function; receptor structure function; response; stargazin; structural biology; thermostability; tool; trafficking

PROJECT SUMMARY AMPA-subtype ionotropic glutamate receptors, which mediate fast signaling between neurons and contribute to high cognitive processes, are also implicated in numerous neurological diseases, including Alzheimer's disease, amyotropic lateral sclerosis, epilepsy and ischemia. The ability to regulate AMPA receptors is therefore an important clinical goal. There is, however, an unmet need for drugs to regulate AMPA receptor activity in pathological conditions that indicates a profound gap in our knowledge of AMPA receptor structure and function. Our long-term goal is to understand how AMPA receptor molecular machinery works at the atomic level. We plan to study AMPA receptor structure and function using advances in single-particle cryo- electron microscopy (cryo-EM). Not only can modern cryo-EM reach similar or better resolution than X-ray crystallography, it can also be used as a powerful tool to analyze heterogeneous populations of AMPA receptor particles and extract structural information that belongs to each individual functional conformation. Because of much more economic sample requirements, cryo-EM can also approach complexes of AMPA receptor with transmembrane regulatory subunits, which are hard to produce in large quantities and demonstrate high degree of conformational and stoichiometric heterogeneity and are thus intractable to X-ray crystallography. Our Specific Aims are to (1) elucidate structural basis of AMPA receptor regulation by auxiliary subunits, (2) determine molecular bases of AMPA receptor activation, and (3) establish molecular mechanism of AMPA receptor desensitization. To reach our goals, we will use cryo-EM to obtain structures of rat GluA2 in complex with different auxiliary subunits in the presence of competitive antagonists, agonists and/or positive allosteric modulators. We will use Fluorescence-detection Size Exclusion Chromatography (FSEC) and thermostability assays to assess protein expression, assembly, homogeneity and stability. We will also employ site-directed mutagenesis and electrophysiological recordings to study functional mechanisms and to critically test our structural models. Reaching our research goals will have a significant impact on understanding the mechanisms of excitatory neurotransmission and will provide molecular-level knowledge essential to facilitate design of new drugs to treat neurological diseases.

项目总结 AMPA亚型离子型谷氨酸受体，介导神经元之间的快速信号传递，并在 到高级认知过程，也与许多神经疾病有关，包括阿尔茨海默氏症 疾病、肌萎缩侧索硬化症、癫痫和脑缺血。调节AMPA受体的能力是 因此这是一个重要的临床目标。然而，对调节AMPA受体的药物的需求还没有得到满足。 病理条件下的活性表明我们对AMPA受体结构的了解存在深刻的差距 和功能。我们的长期目标是了解AMPA受体分子机制是如何在 原子水平。我们计划利用单颗粒冷冻技术的进展来研究AMPA受体的结构和功能。 电子显微镜(冷冻-EM)。现代低温EM不仅可以达到与X射线类似或更好的分辨率 结晶学，它也可以作为一个强大的工具来分析AMPA受体的不同群体 并提取属于每个单独功能构象的结构信息。因为. 更经济的样品需求，冷冻-EM还可以接近AMPA受体与 跨膜调节亚基，很难大量生产，表现出很高的 具有一定程度的构象和化学计量的异质性，因此对X射线结晶学来说很难处理。 我们的具体目的是(1)阐明辅助亚基调节AMPA受体的结构基础，(2) 确定AMPA受体激活的分子基础；(3)建立AMPA的分子机制 受体脱敏。为了达到我们的目标，我们将使用冷冻-EM技术获得大鼠GluA2复合体的结构 在竞争性拮抗剂、激动剂和/或正变构存在的情况下具有不同的辅助亚基 调制器。我们将使用荧光检测尺寸排除层析(FSEC)和热稳定性 用于评估蛋白质表达、组装、均质性和稳定性的分析。我们还将采用现场定向 诱变和电生理记录以研究功能机制，并关键地测试我们的 结构模型。实现我们的研究目标将对理解 兴奋性神经传递的机制，并将提供分子水平的必要知识，以促进 设计治疗神经系统疾病的新药。